Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43141 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-16 | 2021-01-28 | 120497 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2024-02-08 | 2025-01-30 | 218940 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120908 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2020-07-23 | 2021-01-28 | 120914 |
| TEVA-GABAPENTIN | 800MG | TABLET | Avoided shortage | 2025-01-30 | 2025-03-13 | 249201 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-09-23 | 2021-10-07 | 146118 |
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-07-22 | 2021-09-02 | 142905 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2021-08-13 | 2021-10-07 | 144111 |
| TEVA-GABAPENTIN | 600MG | TABLET | Actual shortage | 2025-04-24 | 2025-05-02 | 255698 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-29 | 2021-11-05 | 143262 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2020-07-30 | 2020-09-17 | 121506 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-17 | 2017-04-25 | 3124 |
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181617 |
| TEVA-GABAPENTIN | 800MG | TABLET | Actual shortage | 2025-04-10 | 2025-05-08 | 254786 |
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-01-15 | 2021-02-11 | 131694 |
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2020-10-01 | 2020-10-30 | 125494 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183422 |
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-02-09 | 2023-04-28 | 184189 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2021-03-18 | 2021-04-21 | 135965 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| ACT DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 |